[Pharmacokinetics of ceftizoxime with and without probenecid]. 1982

D Adam, and R Timmler

Serum concentrations and urinary recovery of ceftizoxime were investigated in 18 healthy volunteers. The substance was given as a bolus (2 min) i.v. injection. In volunteers the injection was preceded by orally administered probenecid, 500 mg, 7 and 1 h before (Group II); the remaining 12 volunteers received medication. 5 min after the injection, the serum concentration in Group I was 107 +/- 22 micrograms/ml and in II 93 +/- 18 micrograms/ml in the mean; 30 min after the injection in I 45 +/- 8 micrograms/ml and 44 +/- 10 micrograms/ml in II. The further of the serum concentration was slower in II than in I: serum concentration 6 h after the injection was 2.6 +/- 0.9 micrograms/ml in I and 4.4 +/- 2 micrograms/ml in II. During the first 8-h period 81% of the administered cephalosporin was recovered in the urine of I and 58% in the urine of II. t/2 beta was calculated for I with 1.76 h and 2.13 h for II. The distribution volume was equal, so that the differences in serum concentrations could be explained by the reduced renal clearance: from 2.1 to 1.4 ml/s. Because the comparison was done with two independent groups and furthermore only 6 volunteers participated in the probenecid group, only the difference in the urine in the first 2 h was statistically significant.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Adam, and R Timmler
August 1983, The Journal of antimicrobial chemotherapy,
D Adam, and R Timmler
June 1981, British journal of clinical pharmacology,
D Adam, and R Timmler
September 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
D Adam, and R Timmler
January 1985, European journal of clinical pharmacology,
D Adam, and R Timmler
November 1982, The Journal of antimicrobial chemotherapy,
D Adam, and R Timmler
January 1981, Clinical pharmacokinetics,
D Adam, and R Timmler
September 2008, Antimicrobial agents and chemotherapy,
D Adam, and R Timmler
November 1981, International journal of clinical pharmacology, therapy, and toxicology,
D Adam, and R Timmler
September 1992, The Journal of infectious diseases,
D Adam, and R Timmler
June 1985, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!